133 related articles for article (PubMed ID: 7905364)
1. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
Oka K; Nakano T; Arai T
Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
[TBL] [Abstract][Full Text] [Related]
2. Lymphoepithelioma-like carcinoma of the uterine cervix with c-erbB-2, p53 oncoprotein expression and DNA quantification.
Walsh CB; Kay E; Prendiville W; Turner M; Leader M
Histopathology; 1993 Dec; 23(6):592-3. PubMed ID: 7906245
[No Abstract] [Full Text] [Related]
3. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
[TBL] [Abstract][Full Text] [Related]
4. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy.
Nakano T; Oka K; Taniguchi N
Cancer Res; 1996 Jun; 56(12):2771-5. PubMed ID: 8665512
[TBL] [Abstract][Full Text] [Related]
5. Oncoprotein c-erbB-2 in squamous cell carcinoma of the uterine cervix and evaluation of its significance in response of disease to treatment.
Bhadauria M; Ray A; Grover RK; Sharma S; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2001 Apr; 45(2):191-8. PubMed ID: 11480225
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
8. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma.
Oka K; Nakano T; Arai T
Cancer; 1993 Jul; 72(1):160-4. PubMed ID: 8508400
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
Hale RJ; Buckley CH; Fox H; Williams J
J Clin Pathol; 1992 Jul; 45(7):594-6. PubMed ID: 1355495
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
11. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
12. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy.
Nishioka T; West CM; Gupta N; Wilks DP; Hendry JH; Davidson SE; Hunter RD
J Cancer Res Clin Oncol; 1999; 125(2):96-100. PubMed ID: 10190316
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
16. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
Costa MJ; Walls J; Trelford JD
Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-erbB-2 gene in human head and neck carcinoma.
Craven JM; Pavelic ZP; Stambrook PJ; Pavelic L; Gapany M; Kelley DJ; Gapany S; Gluckman JL
Anticancer Res; 1992; 12(6B):2273-6. PubMed ID: 1363518
[TBL] [Abstract][Full Text] [Related]
18. Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease.
Biesterfeld S; Schuh S; Muys L; Rath W; Mittermayer C; Schröder W
Oncol Rep; 1999; 6(1):205-9. PubMed ID: 9864429
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
Chiu KY; Loke SL; Ho FC
J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium.
Maruo T; Yamasaki M; Ladines-Llave CA; Mochizuki M
Cancer; 1992 Mar; 69(5):1182-7. PubMed ID: 1739918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
